Big TakeBig Take

China Tests the Limits in the Race for Biotech Power

View descriptionShare

Big Take Asia

We’re taking The Big Take to Asia. Each week, Bloomberg’s Oanh Ha tells a story from the home of the world's most dynamic economies - and the markets, 
100 clip(s)
Loading playlist

China is investing heavily in cutting-edge genetic experiments. It’s part of their quest to become a biotech superpower.

On today’s Big Take Asia Podcast, host K. Oanh Ha, Bloomberg’s Karoline Kan and Oxford University geneticist Andy Greenfield discuss China’s pharmaceutical ambitions and the loose regulatory environment that allows the animal testing industry to thrive.

Read more: China Pushes Boundaries With Animal Testing to Win Global Biotech Race

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 2 playlist(s)

  1. Big Take

    782 clip(s)

  2. Big Take Asia

    100 clip(s)

Big Take

The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the sma 
Social links
Follow podcast
Recent clips
Browse 784 clip(s)